» Articles » PMID: 15109618

The Developmental Origins of the Metabolic Syndrome

Overview
Specialty Endocrinology
Date 2004 Apr 28
PMID 15109618
Citations 176
Authors
Affiliations
Soon will be listed here.
Abstract

Both epidemiological and clinical evidence suggest relationships between the antenatal environment and the risk of developing insulin resistance and associated cardiovascular disease (part of the metabolic syndrome) in middle age. However, interpretation of these findings has been controversial. Recent experimental observations provide considerable evidence for a causal model linking adaptive responses to early environmental cues and the later risk of disease. Evolutionary and life history theory provide possible explanations of why these phenomena have persisted and how they might cause disease. In this article, we review the clinical and experimental perspectives on the "developmental origins of disease" model in the context of these new concepts.

Citing Articles

Stachydrine, a pyrrole alkaloid with promising therapeutic potential against metabolic syndrome and associated organ dysfunction.

Ahmed S, Manna P, Borah J RSC Med Chem. 2024; .

PMID: 39290386 PMC: 11403578. DOI: 10.1039/d4md00425f.


A future food boom rescues the negative effects of early-life adversity on adult lifespan in a small mammal.

Petrullo L, Delaney D, Boutin S, Lane J, McAdam A, Dantzer B Proc Biol Sci. 2024; 291(2021):20232681.

PMID: 38654643 PMC: 11040256. DOI: 10.1098/rspb.2023.2681.


The effect of source of protein fed during pregnancy and lactation on the development of characteristics of metabolic syndrome in male offspring of obese Wistar rats.

Jahan-Mihan A J Nutr Sci. 2023; 12:e113.

PMID: 38025303 PMC: 10660075. DOI: 10.1017/jns.2023.97.


Cardiovascular Risk in Pediatrics: A Dynamic Process during the First 1000 Days of Life.

Calcaterra V, Mannarino S, Garella V, Rossi V, Biganzoli E, Zuccotti G Pediatr Rep. 2023; 15(4):636-659.

PMID: 37987283 PMC: 10661305. DOI: 10.3390/pediatric15040058.


Gut microbiome supplementation as therapy for metabolic syndrome.

Antony M, Chowdhury A, Edem D, Raj R, Nain P, Joglekar M World J Diabetes. 2023; 14(10):1502-1513.

PMID: 37970133 PMC: 10642415. DOI: 10.4239/wjd.v14.i10.1502.